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Point mutations in SIVmac239 Nef disrupting CD4 downmodulation and enhancement of virion infectivity
attenuate viral replication in acutely infected rhesus macaques, but changes selected later in infection fully
restore Nef function (A. J. Iafrate et al., J. Virol. 74:9836–9844, 2000). To further evaluate the relevance of these
Nef functions for viral persistence and disease progression, we analyzed an SIVmac239 Nef mutant containing
a deletion of amino acids Q64 to N67 (64-67Nef). This mutation inactivates the N-distal AP-2 clathrin
adaptor binding element and disrupts the abilities of Nef to downregulate CD4, CD28 and CXCR4 and to
stimulate viral replication in vitro. However, it does not impair the downmodulation of CD3 and class I major
histocompatibility complex (MHC-I) or MHC-II and the upregulation of the MHC-II-associated invariant
chain, and it has only a moderate effect on the enhancement of virion infectivity. Replication of the 64-67Nef
variant in acutely infected macaques was intermediate between grossly nef-deleted and wild-type SIVmac239.
Subsequently, three of six macaques developed moderate to high viral loads and developed disease, whereas the
remaining animals efficiently controlled SIV replication and showed a more attenuated clinical course of
infection. Sequence analysis revealed that the deletion in nef was not repaired in any of these animals. However,
some changes that slightly enhanced the ability of Nef to downmodulate CD4 and moderately increased
Nef-mediated enhancement of viral replication and infectivity in vitro were observed in macaques developing
high viral loads. Our results imply that both the Nef functions that were disrupted by the 64-67 mutation and
the activities that remained intact contribute to viral pathogenicity.
The nef gene is conserved among all human and simian
immunodeficiency viruses (HIV and SIV, respectively). Nef is
dispensable for efficient viral replication in many cell culture
systems but critical for the full pathogenic potential of primate
lentiviruses (4, 20, 36, 37). Several Nef activities that likely
contribute to efficient viral spread and disease progression are
conserved among HIV type 1 (HIV-1) and SIVmac. These
include downmodulation of CD4, CD28, and class I and II
major histocompatibility complexes (MHC-I and -II, respec-
tively); upregulation of the invariant chain (Ii) associated with
immature MHC-II molecules; enhancement of virion infectiv-
ity; and stimulatory effects on virus replication in primary T
cells (1–3, 5, 8, 14, 18, 24–26, 28, 30, 40, 41, 44, 46, 55, 56, 59,
63). In contrast to HIV-1, the SIVmac Nef also efficiently
downmodulates CD3 surface expression (7, 31). Studies with
SIVmac Nef mutants selectively altered in some functional
aspects indicate that most or all of these activities mediate
some selective advantage in vivo and might contribute to viral
pathogenesis (22, 34, 47, 48, 54, 61). However, their relative
contributions to the virulence of SIVmac and HIV-1 remained
largely elusive.
Downmodulation of CD4, the primary receptor of HIV and
SIV, is one of the best established Nef functions. The viral Env
protein and the accessory HIV-1 Vpu protein also participate
in CD4 downmodulation, suggesting that this function is crit-
ical for efficient viral spread in the infected host (reviewed in
references 15, 21, 39, and 66). The mechanism of Nef-medi-
ated CD4 downmodulation has been extensively studied. Nef
induces CD4 endocytosis via the AP-2 clathrin adaptor path-
way, and this probably involves the formation of ternary com-
plexes comprising Nef, CD4, and AP-2 (29, 50), analogous to
the previously reported CD3-Nef-AP-2 complex (62). The in-
ternalized CD4 is degraded in an acidic compartment (23, 29,
50). The physiological relevance of CD4 downmodulation is
less clear, but it has been suggested that this activity might
prevent superinfection, facilitate virion release, increase Env
incorporation into virions, and impair T-cell receptor function
(6, 9, 17, 38, 52).
Several lines of evidence indicate that CD4 downmodulation
is important for viral pathogenesis. Nef alleles derived from
some HIV-1-infected long-term nonprogressors are defective
in this function (12, 45, 65). In contrast, HIV-1 nef alleles
obtained during late stages of disease progression show en-
hanced activity (13). It has also been shown that CD4 down-
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modulation by HIV-1 Nef correlates with the efficiency of
HIV-1 replication in primary T lymphocytes (43) and with viral
replication and CD4 T-cell depletion in human lymphoid
tissue ex vivo (27). We have previously analyzed an SIVmac239
variant containing three amino acid substitutions in Nef dis-
rupting the downregulation of CD4 and enhancement of viral
infectivity and replication but not the downmodulation of
CD3, MHC-I, and MHC-II and the upregulation of Ii (34).
These mutations attenuated SIV replication during acute in-
fection. Thereafter, however, viruses containing reversions and
compensatory changes in Nef emerged. Notably, restoration of
the disrupted Nef functions correlated with increasing viral
loads and disease progression. Thus, these results showed that
the ability of Nef to downmodulate CD4 and/or to enhance
viral infectivity is critical for efficient replication during acute
infection but did not provide information on the relevance of
these Nef activities to viral persistence and the clinical out-
come of infection.
To further evaluate the relevance of CD4 downmodulation
to viral replication and pathogenesis, we investigated an SIV
mac239 Nef variant containing a difficult-to-revert deletion of
amino acids Q64 to N67 (64-67Nef). It has been previously
shown that these residues are involved in the interaction of Nef
with AP-2 clathrin adaptor proteins and critical for the efficient
downregulation of CD4, CD28, and CXCR4 and the stimula-
tion of viral replication but not for other Nef functions (32, 42,
63). Here we demonstrate that the 64-67Nef virus shows
pathogenic properties intermediate between wild-type SIVmac
239 and forms containing grossly defective nef genes. In con-
clusion, Nef-mediated CD4 downregulation and enhanced rep-
lication are important in vivo, but other functions also contrib-
ute to the virulence of SIVmac.
MATERIALS AND METHODS
Plasmids and proviral constructs. Generation of bicistronic pCGCG expres-
sion vectors coexpressing the green fluorescent protein (GFP) alone or in con-
junction with the wild-type SIVmac239 (239wt) or 64-67Nef has been described
previously (42, 63). The proviral 239wt clone, the 239(EDR)-Nef mutant, and
NU, containing deletions of 515 bp in the nef-long terminal repeat region, have
been previously described (34, 36).
Cells, virus stocks, and infectivity assays. HeLa CIITA, P4-CCR5, 293T, and
Jurkat cells were cultured as described previously (47, 49, 53). For virus produc-
tion, 293T cells were transfected by the calcium phosphate method (19) with 10
g of the proviral constructs. The medium was changed after overnight incuba-
tion, and virus was harvested 24 h later. The p27 antigen concentrations were
quantified by using an SIV enzyme-linked immunosorbent assay provided by the
NIH AIDS Reagent Program. Cells were infected with virus stocks containing
normalized quantities of p27 antigen, and virus production was measured by
using a reverse transcriptase assay at 2- to 3-day intervals (51). Rhesus blood
mononuclear cells (rPBMC) were isolated as described previously (40), and
immediately infected with aliquots of the virus stocks containing 1 ng of p27
and kept in RPMI 1640 with 10% fetal calf serum (FCS). Residual virus was
removed by washing the cells 16 to 18 h after infection. At 3 days after infection
cells were stimulated with phytohemagglutinin (2 g/ml; Sigma) for 3 days,
washed, and maintained in RPMI 1640 with 20% FCS and 100 U of interleukin-2
(IL-2)/ml. The rhesus T-cell line 221-89 (3) was maintained in the presence of
100 U of IL-2/ml (Boehringer, Heidelberg, Germany) and 20% FCS. Infections
were performed in the absence of exogenous IL-2 or in the presence of 50 U of
IL-2/ml and 5% FCS. In the Nef trans-complementation assay 293T cells were
cotransfected with 4 g of a nef-defective SIVmac239 proviral construct and 3 g
of a bicistronic pCGCG vector expressing Nef. Virus was harvested 3 days
posttransduction and used to infect P4-CCR5 or TZM-bl indicator cells as
described previously (49).
Flow cytometry. Jurkat T cells were either transfected by using the DMRIE-C
reagent (Gibco-BRL) for subsequent detection of CD3, CD4, MHC-I, and
CD28 or electroporated as described previously (32, 33) to analyze the effect
of Nef on CXCR4 surface expression. Efficient transfection with the DMRIE-C
reagent involves stimulation with phytohemagglutinin, which leads to CXCR4
downmodulation. Therefore, Jurkat cells were transfected by using two dif-
ferent methods. HeLa CIITA cells were transfected with Metafectene (Bion-
tex) according to manufacturer’s instructions. Expression of CD3, CD4,
MHC-I, CD28, and CXCR4 on Jurkat T cells and MHC-II or Ii surface
expression on HeLa CIITA cells transfected with bicistronic vector coexpress-
ing Nef and GFP were measured as described previously (32, 53, 54). Quan-
tification of Nef-mediated down- or upregulation of the respective surface
markers was performed as described elsewhere (13, 53, 54). Briefly, the mean
channel numbers of red fluorescence were determined for cells expressing no
(N), low (L), medium (M), or high (H) levels of GFP. The mean channel
numbers of red fluorescence obtained for cells transfected with the nef con-
struct expressing GFP only were divided by the corresponding numbers ob-
tained for cells coexpressing Nef and GFP to calculate the values for X-fold
down- or upmodulation, respectively.
Infection of rhesus macaques. Six juvenile rhesus macaques of Indian origin
were infected by intravenous inoculation of SIVmac239 64-67Nef containing 10
ng of p27 produced by transfected 293T cells. Animals were housed at the
German Primate Center in Gottingen in accordance with the institutional guide-
lines. The macaques were healthy and seronegative for SIV, D-type retroviruses,
and simian T-cell leukemia virus type 1 at the time of infection. Sera and cells
were collected at regular intervals, and serological, virological, and immunolog-
ical analysis was performed as described previously (57, 58, 64).
FIG. 1. Modulation of human cell surface receptors by the SIV
mac239 64-67 Nef. Human CD4 Jurkat T cells (A to E) or HeLa
CIITA cells (F and G) were transiently transfected with plasmids
expressing GFP alone (nef) or together with the 239wt and 64-67
Nef alleles. The surface expression of CD4 (A), MHC-I (B), CD3 (C),
CD28 (D), CXCR4 (E), MHC-II (F), and Ii (G) was measured as
described in Materials and Methods. The results were confirmed in
independent experiments.
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Nef amplification and sequence analysis. Viral plasma RNA was isolated with
the QIAamp RNA Kit (Diagen, Basel, Switzerland) and reverse transcribed with
superscript reverse transcriptase (Gibco-BRL, Eggenstein, Germany). SIV se-
quences spanning the entire nef gene were amplified from cDNA with a nested
PCR approach essentially as described previously (34). All nef alleles were first
cloned into the bicistronic CMV-based pCGCG vector coexpressing GFP and
Nef using XbaI and MluI restriction sites flanking nef. Subsequently, some nef
alleles were introduced into the proviral SIVmac239 genome by splice overlap
extension PCR as described previously (34, 48). All PCR-derived inserts were
sequenced on both strands to confirm that the constructs expressed the correct
Nef variants.
Western blot. 293T cells were transfected with 5 g of pCGCG expression
vectors (42) coexpressing GFP and Nef using the calcium phosphate method as
described previously (11, 54). At two days posttransfection cells were pelleted,
and lysates were generated and separated by sodium dodecyl sulfate–12% poly-
acrylamide gel electrophoresis as described previously (11, 54). Expression of
Nef and p27 in whole cellular lysates was analyzed by immunoblotting. Proteins
were detected with a 1:2,500 dilution of pooled sera from SIVmac239-infected
rhesus macaques and a 1:5,000 dilution of an alkaline phosphatase-conjugated
secondary anti-human immunoglobulin G antibody (Jackson Immunoresearch)
as described by the manufacturer.
GenBank accession numbers. SIVmac239 nef sequences derived from ma-
caques infected with the 64-67Nef variant were submitted to the GenBank
sequence database and have been assigned the accession numbers DQ411004 to
DQ411025.
RESULTS
Functional characterization of the SIVmac239 64-67Nef.
Prior to animal studies, we confirmed and extended the in vitro
characterization of the 64-67Nef. In agreement with previous
reports (32, 42, 63), we found it to be defective in downregulation
of CD4, CD28, and CXCR4 cell surface expression (Fig. 1A, B,
and E). Notably, deletion of residues 64 to 67 did not affect the
activity of Nef in downmodulating CD3 and class I or II MHC
(Fig. 1C, D, and F). The 64-67Nef also upregulated Ii surface
expression albeit with moderately reduced efficiency compared
to 239wt Nef (Fig. 1G). Thus, the 64-67 mutation, which
removes the N-distal AP-2 binding element (42, 63), disrupted
the effect of SIVmac239 Nef on three of the seven cell surface
receptors under study.
Next, we introduced the 64-67Nef into the full-length
SIVmac239 provirus and investigated its effect on viral repli-
cation and infectivity. Infection of the rhesus macaque T-cell
line 221-89 presents a useful system for investigating the ability
of Nef to cause lymphocyte activation (3). As shown in Fig. 2A,
the 64-67Nef was unable to enhance SIVmac239 replication
FIG. 2. Deletion of residues 64 to 67 impairs the ability of Nef to stimulate SIV replication but not to enhance the infectivity of progeny virions.
(A) Replication of SIVmac239 containing wild type (■), 64-67 (Œ), or a disrupted nef gene () in 221-89 cells in the presence (left) or absence
(right) of exogenous IL-2 (100 U/ml). (B) Replication of SIVmac239 nef variants in rhesus PBMC infected immediately after isolation and
stimulated 3 days later. PSL, photon-stimulated light emission. Similar results were obtained in two independent experiments using different virus
stocks. ‚, Uninfected cells. (C) P4-CCR5 cells were infected in triplicate with aliquots of three different 293T cell-derived virus stocks containing
100 ng of p27 core antigen. Infectivity is shown relative to the 239wt virus. U, uninfected cells.
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in 221-89 cells both in the absence and in the presence of
exogenous IL-2. Compared to 239wt the 64-67Nef mutant
virus also replicated with delayed kinetics and reduced effi-
ciency in rPBMC that were infected immediately after isolation
and stimulated 3 days later (Fig. 2B). In most experiments,
however, the 64-67Nef variant replicated slightly better than
the 239nef* containing a disrupted nef open reading frame
(ORF), indicating that it maintains some residual activity in
this assay. Consistent with the published data (42), the 64-
67Nef enhanced virion infectivity, albeit with moderately re-
duced efficiency (Fig. 2C). These results are in agreement with
previous observations with HIV-1 nef, suggesting that Nef-
mediated CD4 downregulation usually correlates with the ef-
ficiency of viral replication in vitro but not with enhancement
of virion infectivity (27, 40, 43). Together, our in vitro data
demonstrate that the 64-67Nef does not efficiently down-
modulate CD4, CD28, and CXCR4 or stimulate viral replica-
tion in vitro but is active in modulating MHC-I, MHC-II, Ii,
and CD3 surface expression and enhancing virion infectivity.
The 64-67Nef attenuates SIV replication during acute in-
fection. Six rhesus macaques were intravenously infected with
SIVmac239 containing the 64-67Nef to evaluate the effect of
this deletion on viral replication and pathogenesis in vivo. As
expected from previous studies (34, 36, 40), peak levels of
plasma viremia and of viral RNA were observed at 2 weeks
postinfection (wpi). During acute infection, the average levels
of p27 plasma antigenemia in the animals that received the
64-67Nef mutant (219  101 pg/ml, n  6) were 16-fold
lower than those detected in 239wt-infected macaques (3,612 
708, n  11) (Fig. 3A). However, they were threefold higher
than those observed in grossly nef-deleted 239NU-infected
macaques (68  23, n  4) and in six animals that received the
239(EDR)-Nef variant (65 30, n 6) (34). In comparison, the
peak levels of viral RNA (2.5 106  4.2 106) in 64-67Nef
infection were only 4.8-fold lower than those observed in the
239wt infection (1.2  107  1.8  106, n  22; P  0.01) but
8.5-fold higher than those observed in macaques inoculated
with the NU variant (2.9 105 1.2 105, n 22; P 0.02)
(Fig. 3B). On average, the levels of RNA were also 13.3-fold
higher than those previously observed in macaques infected
with the 239(EDR)-Nef variant (1.9  10
5  7.7  104, n  6).
Consistent with the intermediate levels of SIVmac239 64-67
replication, the urinary neopterin levels, a marker for nonspe-
cific immune stimulation (58), were also higher than in 239(EDR)-
Nef and NU-infected animals but lower than in 239wt infection
(Fig. 3C). These results demonstrate that the deletion of residues
64 to 67 in Nef attenuates SIVmac239 replication early in infec-
tion. The disruptive effects were less severe, however, than those
of large deletions in NU Nef or the point mutations present in
the 239(EDR)-Nef variant (Fig. 3) (34).
Reduced virulence of SIVmac239 64-67Nef during later
stages of infection. After the acute phase of infection, the viral
loads decrease in the great majority of animals inoculated with
nef-deleted SIVmac239 but usually remain high in animals
infected with 239wt (36). In contrast, the outcome of infection
in the animals infected with the 64-67Nef variant varied. Three
of the six animals—Mm9024, Mm10026, and Mm10027—main-
tained intermediate to high levels of viral RNA and cell-associ-
FIG. 3. Replication of SIVmac239 containing the 64-67 Nef variant early during infection. The peak plasma levels of p27 and viral RNA in
six acutely infected rhesus macaques, which were observed at 2 weeks postinfection, are shown. (A) Levels of p27 plasma antigenemia. The limit
of detection is approximately 10 pg/ml. (B) Viral RNA load. (C) Levels of neopterin, a marker for nonspecific immune activation (58). For
comparison, values obtained from animals infected with 239wt, the grossly nef-defective NU virus, and from six macaques inoculated with the
239(EDR)Nef mutant (34) are also indicated. The upper panels give individual values, and the lower panels indicate the average values  the
standard deviation. U, uninfected cells.
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ated viral loads (Fig. 4, left panels). The remaining macaques—
Mm9044, Mm9051, and Mm10028—developed low RNA loads,
similarly to attenuated NU infection (Fig. 4A, left panel). Fur-
thermore, the cell-associated viral loads were 2 to 3 orders of
magnitude lower than those usually observed in 239wt infection
(Fig. 4B, left panel). Between 12 and 52 wpi, the average RNA
loads in the six animals that were inoculated with the 64-67Nef
mutant (3.5 105 1.6 105) were 27-fold higher compared to
NU infection (1.3  104  6.7  103; P  0.0004) but 22-fold
lower than those in 239wt-infected macaques (7.9  106  4.2 
106; P  0.0015) (Fig. 4A, right panel). Typically, the cell-associ-
ated viral loads declined only marginally after the acute phase of
239wt infection but dropped dramatically in animals that received
the NU or 64-67Nef variants (Fig. 4B, left panel). However, 3
of 6 64-67Nef and 3 of 15 NU-infected macaques showed
increasing cell-associated viral loads after 12 and 20 wpi, respec-
tively (Fig. 4B and data not shown). In contrast, the average
cell-associated virus loads in 239wt-infected animals declined
slowly during later stages of 239wt infection due to the death of
several rapid progressors showing high levels of replication during
the investigation period. On average, the number of infectious
cells increased earlier in64-67Nef-infected animals compared to
NU infection (Fig. 4B, right panel). It is noteworthy that the
cell-associated viral loads in 64-67Nef-infected macaques were
reduced more severely than the viral RNA loads. Consequently,
the plasma RNA copy numbers per infectious cell detected in the
periphery of both 64-67Nef (3,273  693)- and 239wt (5,899 
2,111)-infected macaques were significantly higher than those de-
tected in NU infection (352  70; P  0.0006 and 0.013, re-
spectively; the numbers indicate the average number of RNA
copies per infectious cell  the standard error of the mean
[SEM]).
Consistent with the variable efficiency of viral replication,
the six animals infected with the 64-67Nef variant showed
differential clinical courses of infection. The two animals with
the highest viral loads, Mm9024 and Mm10026, showed declin-
ing CD4 T-cell numbers after 16 wpi and developed a mod-
erate lymphadenopathy by 4 wpi. Mm9024 also developed in-
creasing thrombocytopenia after 6 wpi and persistent splenomegaly
by 16 wpi and had to be euthanized by 69 wpi because of
diarrhea and severe immunodeficiency. Histopathological ex-
amination revealed moderate to severe follicular hyperplasia
with progression to depletion of multiple lymphatic organs and
a chronically active gastroenteritis induced by opportunistic
infections (Giardia). Mm10026 also became immunodeficient,
and autopsy at 53 wpi revealed a moderate chronically active
gastroenteritis partially induced by parasites, SIV-induced ar-
teriopathy of the respiratory tract, and severe generalized lym-
phatic hyperplasia with the beginning of a pleomorphic malig-
nant lymphoma in some lymph nodes and spleen. The third
animal that showed relatively high viral loads after infection
with the 64-67Nef variant, Mm10027, developed a persistent
mild lymphadenopathy from 8 wpi and a mild anemia and
thrombocytopenia after 28 wpi. Histological examination at 53
wpi revealed mild generalized follicular hyperplasia in lym-
phatic organs. Consistent with the low viral loads detected in
Mm9044, this animal remained healthy with stable CD4 counts
throughout the observation period and was euthanized at 75
wpi. Postmortem examination revealed no clinical abnor-
malities except a mild hyperplasia in lymphatic tissues.
FIG. 4. Persistence of the SIVmac239 64-67 Nef variant in rhesus macaques. (A) Viral RNA load and (B) number of infectious cells per 1
million PBMC. The right panels show average values  the standard deviations. For comparison, values obtained from macaques infected with
SIVmac239 NU () or wild-type SIVmac239 (■) are indicated. Parameters were determined as described in Materials and Methods.
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Mm9051 also did not show signs of immunodeficiency, except
for a mild lymphadenopathy occurring between 4 and 48 wpi.
Autopsy was performed at 75 wpi and revealed a moderate
generalized follicular hyperplasia in lymphatic tissues and gen-
eralized lymphatic activation but no opportunistic infections.
Despite low levels of viral replication (Fig. 4) Mm10028
showed a decline in the number of CD4 T cells after 36 wpi
and developed a persistent anemia by 20 wpi, which was severe
at necropsy at 54 wpi. Histopathological examination revealed
a moderate to severe chronic active gastroenteritis and a mod-
erate interstitial pneumonia.
In summary, all six animals infected with the 64-67Nef
variant became slow progressors and survived at least 1 year
after infection, whereas ca. 70% of the SIVmac 239-infected
rhesus macaques developed severe immunodeficiency and died
within this time period. However, two animals (Mm9024 and
Mm10026) with high viral loads developed AIDS. In contrast,
Mm9044 and Mm9051 with low viral loads remained clinically
healthy during the 75-week observation period. The remaining
two macaques, Mm10027 with intermediate viral loads and
Mm10028 with low viral loads, showed signs of progressive
infection but did not develop AIDS for about 1 year of follow-
up. Thus, both the replicative capacity and the pathogenetic
properties of the 64-67Nef variant were intermediate be-
tween 239wt and NU.
Nef sequence alterations selected in vivo. Three of the six
animals infected with the 64-67Nef variant (Mm9024, Mm10026,
and Mm10027, [designated Mm-M for moderate]) developed
viral loads that were moderately reduced compared to the
pathogenic SIVmac 239wt, whereas the remaining three ma-
caques (Mm9044, Mm9051, and Mm10028 [designated Mm-L
for low]) showed more attenuated levels of viral replication
resembling grossly nef-deleted NU infection (Table 1 and
Fig. 4). It is known that small deletions in nef can be “repaired”
and function can be restored during the course of SIV infec-
tion (11, 67). Therefore, we next investigated whether the
different levels of viral replication observed in the six animals
infected with the 64-67Nef variant correlate with reversions
or second-site compensatory changes in Nef. Sequence analysis
of PCR fragments amplified from plasma viral RNA at sequen-
tial time points revealed that the 64-67 deletion in nef was not
repaired in any of the six animals (Fig. 5). However, as sum-
marized in Table 1, the frequency of nucleotide changes and
deduced amino acid substitutions was 3-fold higher in the
three animals with high viral loads. Although this may be the
consequence rather than the cause of efficient replication, it is
noteworthy that 91% of the nucleotide changes in Mm-M but
only 75% in Mm-L were nonsynonymous. Moreover, all 36 nef
ORFs derived from Mm-M at 24 or 40 wpi predicted full-
length proteins, whereas 12 of the 40 sequences derived from
TABLE 1. Viral load and changes in nef in macaques infected with the 64-67Nef variant
Animala wpib
Viral loadc nef sequence analysisd
RNA copies Cell associated No. of nef allelesanalyzed No. of ns/nef No. of aas/Nef
No. of
non-synonymous
changes (%)
Mm9024 24 1.3 106 256 5 (0) 8.0 7.6 95
40 2.3  106 512 4 (0) 14.8 14.5 98
Ln69 128 5 (1) 9.8 9.4 96
Mm9044 24 b.d.l. 0.33 4 (1) 1.8 1.3 71
40 b.d.l. 	0.33 5 (1) 1.2 1.2 100
Mm9051 24 4.5 104 0.33 5 (0) 6.6 5.6 85
40 2.1  104 1 4 (0) 1.3 1.3 100
Mm10026 24 3.1 105 67 5 (0) 12.6 11.2 89
40 1.2  106 512 11 (0) 8.5 7.7 91
Ln53 512 6 (1) 10.3 9.3 90
Mm10027 24 2.0 105 256 5 (0) 10.2 8.0 78
40 1.6  105 256 6 (0) 6.2 5.5 89
Ln53 128 4 (0) 4.8 4.3 89
Mm10028 24 1.5 103 1 3 (2) 5.0 4.3 87
40 1.6  102 1 7 (8) 5.3 3.9 74
Ln54 0.1 5 (0) 1.4 1.2 86
Mm-M 9.1 105  8.5  105 310  173 36 (0) 10.1 3.2 9.1  3.2 91
Mm-L 1.1 104  1.8  104 0.7  0.4 28 (12) 3.5 2.4 2.9  1.9 75
a Mm-M refers to the three animals with medium (Mm9024, Mm10026, and Mm10027), and Mm-L are animals with low viral loads (Mm9044, Mm9051, and
Mm10028).
b Parameters were determined at the indicated weeks postinfection (wpi), except the cell-associated viral loads for Mm10026, Mm10027, and Mm10028, which were
obtained at 36 wpi. Ln, lymph node.
c Viral loads were measured as described in the legend to Fig. 4. b.d.l., below detection limit (40 copies/ml).
d Numbers of intact and defective (in parentheses) nef genes per sample analyzed. The average frequency of nucleotide and amino acid changes (ns and aas,
respectively) were only calculated for full-length nef ORFs.
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Mm-L were truncated (Table 1). These results indicate a high
selective pressure for amino acid changes and full-length Nef
expression in animals that developed relatively high viral loads.
To further assess the Nef sequence alterations selected in vivo,
we also analyzed genomic DNA samples derived from lymph
nodes obtained at necropsy. env-nef fragments could be readily
amplified from the three animals with moderate to high viral
loads (Mm9024, Mm10026, and Mm10027) but only from one
animal with low viral loads (Mm10028). The results confirmed
that the 64-67 deletion was stable and that a larger number of
changes was observed in the nef sequences derived from the
three animals with the relatively high viral loads compared to
Mm10028 showing low viral loads (Table 1).
Importantly, at five positions (M7, E75, A136, E191, and
Y193) amino acid substitutions were observed in at least two of
the three macaques with relatively high viral loads but not in
the remaining animals (Fig. 5). Of these alterations the E191K
and Y193C changes were most interesting because they were
consistently observed in Mm-M infection and became predom-
inant in animals Mm9024 and Mm10026, which developed the
most severe clinical symptoms. Furthermore, they are located
in the ExxxLM sequence, which may be involved in the inter-
FIG. 5. Alignment of Nef sequences derived from macaques infected with the SIVmac239 64-67 Nef variant. The SIVmac239 sequence is
shown in the upper panel for comparison. Dots indicate amino acid identity, and dashes indicate gaps introduced to optimize the alignment. Some
sequence motifs in Nef, including the N-terminal myristoylation signal, the acidic region, a C-proximal adaptor-protein (AP) interaction site, and
the position of the 64-67 deletion are indicated. The “#” symbol denotes positions where changes in Nef were selected in several animals. The
numbers in parenthesis give the number of clones analyzed. w, wpi; Ln, lymph node.
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action of Nef with clathrin adaptor protein complexes (10, 18)
and critical for downmodulation of CD4 and CD28 (63), as
well as upregulation of Ii by SIVmac239 Nef (53, 59). Notably,
HIV-1 Nef proteins do not contain the N-terminal AP-binding
motif, and some HIV-1 Nef proteins contain a cysteine at the
position corresponding to Y193 in SIV Nef. Thus, the Y193C
change might partially compensate for the loss of the N-ter-
minal AP-2 binding element in 64-67 SIV Nef by generating
a more “HIV-1-like” C-terminal sequence. In addition to these
point mutations, 45 nucleotides flanking the 64-67 mutation
were deleted in three of five nef alleles derived from Mm10027
at 24 wpi, predicting the deletion of amino acid residues 61 to
80 (Fig. 5). The majority of nef alleles derived from Mm9044 at
24 wpi and from Mm10028 at both 24 and 40 wpi also con-
tained a mutation of AAAAGAAAAGGGGGG to AAAAA
AAAAGGGGGG in the polypurine tract, predicting the sub-
stitution of E125K (Fig. 5).
Functional activity of Nef variants selected in vivo. Our
observation that some changes were consistently observed in
nef alleles derived from animals with relatively high viral loads,
suggested that they may functionally compensate for the 64-
67Nef deletion. To evaluate this possibility, representative nef
alleles PCR amplified from the six animals at 24 and 40 wpi
were cloned into the bicistronic vector coexpressing Nef and
GFP for flow cytometric analysis. Western blot analyses re-
vealed that, with the exception of the 9,044-k6 allele containing
a premature stop codon at position 122 of the nef ORF, all Nef
variants were expressed in transfected 293T cells (Fig. 6 and
data not shown). The electrophoretic mobility differed from
that of the 239wt Nef due to the 64-67 and 61-80 deletions
and the presence of up to 10 amino acid substitutions.
Flow cytometric analysis revealed that the ability of Nef to
efficiently downmodulate CD4, CD28, and CXCR4 was not
restored in any of the six animals infected with the 64-67Nef
variant (examples shown in Fig. 7A). In contrast, all intact nef
alleles derived from these animals efficiently modulated sur-
face expression of CD3, MHC-I, MHC-II, and Ii. For quanti-
tative fluorescence-activated cell sorting analysis, we divided
the mean fluorescence intensity obtained on Jurkat or HeLa
CIITA cells transiently transfected with the different nef alleles
by the mean fluorescence obtained for cells transfected with a
nef-defective control construct as described previously (13, 53).
As shown in Fig. 7B, all nef alleles selected in vivo showed little
if any activity in downmodulating CD4 and CD28. They were
functionally active, however, in modulating the remaining sur-
face receptors investigated, albeit with different efficiencies.
Finally, we evaluated whether more subtle differences in Nef
function are associated with the development of relatively high
or low load viral loads in vivo. We compared the average
activities of seven nef alleles derived from the three Mm-M
animals with high viral loads (Mm9024, Mm10026, and
Mm10027) at 24 or 40 wpi with those derived from the remain-
ing Mm-L macaques. At these time points, the virals loads
differed by 2 to 3 orders of magnitude between the two groups
of animals (Table 1). Quantitative analysis revealed some mi-
nor restoration of CD4 but not CD28 or CXCR4 downmodu-
lation in animals with high viral loads (Fig. 7C and data not
shown). In contrast, the functional activity in CD3 downregu-
lation was reduced at high levels of Nef expression. Notably,
most nef alleles selected in vivo showed enhanced activity in Ii
upregulation compared to the 64-67Nef (Fig. 7C). Finally,
both groups of animal-derived nef alleles and the 64-67Nef
showed similar activities in modulating MHC-I and MHC-II
surface expression. Thus, the differences in viral loads in the
animals that received the 64-67Nef mutant did not correlate
with efficient restoration of CD4 and CD28 downmodulation.
However, nef alleles derived from animals with low or high
viral loads showed some subtle differences in their abilities to
downregulate CD4 and CD3 surface expression.
To evaluate whether the changes selected in macaques in-
fected with the 64-67Nef variants restored the ability of Nef
to stimulate SIV replication, we introduced the animal-derived
nef alleles obtained at 24 wpi into the 239wt provirus and
assayed the effects of these nef variants on the replicative
capacity of SIVmac 239 in 221-89 cells. In the absence of
exogenous IL-2, only the parental 239wt virus replicated effi-
ciently (Fig. 8A), demonstrating that none of the changes se-
lected in vivo fully restored this Nef function. In the presence
of IL-2, however, several nef alleles were more active in en-
hancing SIV replication than the original 64-67Nef (Fig. 8B).
Those derived from Mm9024 and Mm10027 showed the high-
est activity and resulted in levels of replication intermediate
between 239wt and the 64-67Nef variant. In comparison,
SIVmac239 containing the 9044-k9 and 10026-k20 nef alleles
replicated only slightly better than the original 64-67Nef mu-
tant virus. Finally, introduction of the 9051-k11 and 10028-k30
nef alleles resulted in inefficient replication in 221-89 cells. In
addition to the changes in nef, the G-A mutations in the poly-
purine tract of sequences derived from Mm9044 and Mm10028
described above might also affect the efficiency of viral repli-
cation. Furthermore, the Mm10028 nef alleles contained
changes of TTTTAT to TTCTAT (24 wpi) and TTGTAT or
TTGAAT in the T-rich region just upstream the polypurine
tract, which is known to be important for efficient replication of
SIVmac239 (32). On average, the reverse transcriptase pro-
duction in 221-89 cells infected with SIVmac239 carrying nef
alleles derived from the three animals with high viral loads was
intermediate (78.3  24.4, n  12) between 239wt (100%) and
64-67Nef (47.2  1.4, n  3) infection (Fig. 8C). In contrast,
intact nef alleles derived from animals with low viral loads did
not enhance viral replication (44.1  18.6, n  9).
Finally, we examined the ability of nef variants to enhance
the infectivity of SIVmac. To avoid a possible bias due to
FIG. 6. Expression of nef alleles selected in SIVmac239 64-
67Nef-infected macaques. 293T cells were transfected with proviral
SIVmac239 constructs encoding the indicated Nef proteins or contain-
ing a disrupted nef gene (nef*). Pooled sera from SIVmac239-infected
rhesus macaques were used for the detection of Nef and p27, respec-
tively.
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changes in overlapping env or LTR sequences, we expressed
Nef in trans in the virus producer 293T cells. The 239wt Nef
enhanced viral infectivity in TZM-bl cells 20-fold (Fig. 9A).
The 64-67Nef showed 2-fold reduced activity (50.2% 
8.8%, n  9; numbers give mean infectivity  the SEM as a
percentage of that obtained for 239wt Nef). Unexpectedly, nef
alleles derived from six animals infected with the 23964-
67Nef variant differed considerably in their ability to promote
viral infectivity (Fig. 9A). These differences were highly repro-
ducible and confirmed in two different indicator cell lines (Fig.
9B). Importantly, nef alleles derived from the three animals with
relatively high viral loads were usually more active (59.4% 
7.3%, n  45) than those derived from macaques showing more
attenuated levels of viral replication (24.3% 2.5%, n 36; P	
0.0001) (Fig. 9A). Taken together, our results show that the
second-site mutations in Nef selected in animals with moderate
to high viral loads slightly increased the ability of the 64-
67Nef to downmodulate CD4 and had more significant effects
on its ability to enhance viral replication and infectivity in vitro.
DISCUSSION
Disrupting the N-distal AP-2 binding element in SIV Nef
eliminates downregulation of CD4, CD28, and CXCR4 (32, 42,
63). We demonstrate that this mutation attenuates viral repli-
cation both in vitro and in vivo in infected rhesus macaques.
Attenuation was clearly less severe, however, than that achieved
by large deletions that disrupt all aspects of Nef function. There-
FIG. 7. Functional activity of nef alleles derived from SIVmac239 64-67Nef-infected macaques. (A) Jurkat T (rows A to D) or HeLa-CIITA
(rows E and F) cells were transfected with bicistronic vectors coexpressing the indicated nef alleles and GFP and assayed for surface expression
of CD4, CD3, CD28, MHC-I, MHC-II, and Ii. (B) Quantitative analysis of the functional activity of individual nef alleles. Ranges for green
fluorescence on cells defined as expressing no (N), low (L), medium (M), or high (H) levels of GFP are indicated in panel A. X-fold down- or
upmodulation was calculated as described in Materials and Methods. (C) Average activities  the standard deviations of nef alleles derived from
macaques with relatively high (H) or low (L) virus loads. Values are shown relative to the activity, calculated as the X-fold modulation of the
respective receptors at high expression levels, of the SIVmac 239wt Nef protein (100%). , Activity of the original 64-67Nef. The effect of several
Nef proteins on CD3 was saturated at medium expression levels. Therefore, CD3 downmodulation was calculated for both medium and high levels
of GFP expression.
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fore, some or all of the functions that were not disrupted by the
64-67 deletion, such as downmodulation of class I MHC and
CD3, upregulation of Ii cell surface expression, or the increased
virion infectivity also contribute to viral replication in vivo. These
findings are consistent with the accumulating evidence suggesting
that a combination of multiple separable Nef functions enables
both SIV and HIV to replicate efficiently and to persist at high
levels in the infected host (11, 22, 34, 47–49, 54, 61).
Early in infection the 64-67Nef variant replicated with sig-
nificantly higher efficiency than the 239(EDR)Nef mutant ana-
lyzed in our previous study (34). Both mutant nef alleles were
defective in downmodulating CD4, CD28, and CXCR4 and in
stimulating viral replication. The major functional difference
between them is that the 64-67Nef shows only moderately
reduced activity in enhancing virion infectivity (Fig. 2), whereas
the 239(EDR)Nef is entirely inactive (34). Although we compared
their functional activity in nine in vitro assays (CD4, MHC-I,
CD3, CD28, CXCR4, MHC-II, Ii, infectivity, and replication), the
possibility that both nef alleles also differ in other functional as-
pects cannot be dismissed. Nonetheless, our findings suggest that
Nef-mediated infectivity enhancement, while insufficient for effi-
cient stimulation of SIV replication in PBMC and in 221-89 cell
cultures, may accelerate viral replication in infected macaques at
early stages of infection. Moreover, our finding that nef alleles
derived from macaques with progressing disease were signifi-
cantly more active in enhancing viral infectivity than those ob-
tained from macaques showing a more strongly attenuated course
of infection suggests that this Nef function also contributes to viral
spread and pathogenicity during later stages of infection.
Altogether, the SIVmac239 64-67Nef variant showed patho-
genic properties intermediate between 239wt and grossly nef-
deleted SIVmac infection. The efficiencies of viral replication and
FIG. 8. Activity of nef alleles derived from SIVmac239 64-67Nef-infected animals at 24 wpi in enhancing viral replication. Replication of the
indicated SIVmac239 nef variants in 221-89 cells in the absence (A) or presence (B) of exogenous IL-2. The reverse transcriptase activity was
determined by using a phosphorimager. PSL, photon-stimulated light emission. Similar results were obtained in three independent experiments.
(C) Virus production by 221-89 cells infected in the presence of IL-2 with SIVmac239 variants expressing the 239wt and 64-67 Nefs or nef alleles
derived from the three animals with moderate (Mm-M, Mm9024, Mm10026, and Mm10027) or low (Mm-L, Mm9044, Mm9051, and Mm10028)
viral loads. For each virus variant, we determined the total reverse transcriptase activity in the culture supernatants over the 18-day period. The
reverse transcriptase values obtained for 239wt were considered 100%. Means and SEMs derived from three experiments are shown.
FIG. 9. Activity of nef alleles derived from SIVmac239 64-67Nef-infected animals in enhancing viral infectivity. (A) TZM-bl cells were
infected with virus stocks produced in 293T cells expressing no Nef (nef*) or the indicated SIVmac239 nef alleles. The infectivities are shown
relative to those obtained using 239wt Nef (100%). Average values ( the SEM) derived from triplicate infections (each) with three independent
virus stocks are given. (B) Correlation between the infectivities of viral stocks quantified in TZM-bl or P4-CCR5 cells.
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the clinical course of infection differed among the six 64-67Nef-
infected animals. Half of the animals showed only moderately
reduced viral loads compared to pathogenic 239wt infection and
progressed slowly to immunodeficiency, whereas the remaining
macaques remained asymptomatic and resembled grossly nef-
deleted infection. Nef sequence analysis revealed that the dele-
tion was not repaired in any of these animals during the course of
infection. Furthermore, in contrast to the results obtained using
the 239(EDR)Nef variant (34), the disrupted Nef functions were
not efficiently restored in 64-67Nef-infected macaques. How-
ever, some second-site mutations in Nef were consistently se-
lected in animals that developed relatively high viral loads. Func-
tional analysis revealed that these changes had some minor
restorative effects on CD4 downmodulation and moderately en-
hanced the ability of the 64-67Nef to enhance viral replication
and infectivity in vitro. The fact that these alterations were only
observed in animals developing relatively high viral loads and
showing signs of disease progression suggests that the alterations
contributed to efficient viral replication and pathogenesis in in-
fected animals. However, given that Nef function was not fully
restored, it is quite possible that changes elsewhere in the viral
genomes contributed to this phenotype.
The 64-67Nef is impaired in two functions interfering with
T-cell activation: the downmodulation of CD4 and CD28.
However, it was even more active than 239wt Nef in down-
regulating CD3 from the cell surface. This function might be
advantageous for the virus because it interferes with TCR-
mediated T-cell activation by antigen-presenting cells and
hence likely weakens the antiviral immune response. However,
efficient CD3 downregulation is not sufficient to enhance SIV
replication in infected macaques (48). We found that nef al-
leles derived from the two 64-67Nef-infected animals with
the highest viral loads, Mm9024 and Mm10027, were less ac-
tive than 64-67Nef in downmodulating CD3 cell surface ex-
pression. While the relevance of these subtle functional differ-
ences for viral replication in vivo remains elusive one could
speculate that the reduced functional activity in CD3 down-
modulation could lead to increased activation of infected T
cells and hence increased virus production.
All nef alleles derived from 64-67Nef-infected macaques with
relatively high viral loads predicted full-length reading frames
and, as discussed above, contained amino acid changes that en-
hanced viral fitness. In contrast, nef ORFs were disrupted more
frequently in animals with low viral loads, although fewer nucle-
otide changes were selected (Table 1). At 24 wpi, changes of
AAAAGAAAAGGGGGG to AAAAAAAAAGGGGGG were
consistently detected in Mm9044 and Mm10028, which both
showed low viral loads. Unaltered polypurine tract sequences
were detected later in Mm9044 infection. In Mm10028, however,
additional changes in the PPT and the critical upstream T-rich
region (35, TTTTATAAAAGAAAAGGGGGG to TTGAATA
AAAAAAAAGGGGGG were also present at 40 wpi. Further-
more, the majority of nef genes were prematurely truncated
(Table 1). Thus, it seems that in Mm10028 less fit viral variants
predominated later during infection. Consistent with this, the
viral RNA load in Mm10028 dropped by 2 orders of magnitude
between 20 and 40 wpi, and no infectious cells could be detected
after 36 wpi (Fig. 4). Less-fit viral variants have also been detected
in some nonprogressors or slow progressors of HIV-1 infection
(12, 45, 65).
It has been shown that Nef-mediated downregulation of
class I MHC complexes from the cell surfaces protects infected
cells from detection and lysis by cytotoxic T lymphocytes
(CTL) (16). In agreement with an important role of this Nef
function in vivo it has been demonstrated that MHC-I down-
modulation is associated with a strong selective advantage (47,
61). It is thought that the emerging antiviral CTL response
plays a key role in the control of viral replication after the
acute phase of infection. Deletion of residues 64 to 67 did not
reduce the ability of 239-Nef to downregulate surface expres-
sion of class I MHC complexes. Thus, it was unexpected that
the cell-associated viral loads dropped as dramatically in the six
animals that received the 64-67Nefs variant as in macaques
infected with grossly nef-deleted NU virus (Fig. 4B). Remark-
ably, the viral RNA levels in the plasma of 64-67Nef-infected
animals dropped less strongly (Fig. 4A). Thus, cells infected
with the 64-67Nef variant might produce more virus than
those infected with the NU virus. It is also possible, how-
ever, that our measurement of viral loads in the peripheral
blood of the 239wt, NU, and 64-67Nef-infected macaques may
not accurately reflect the number of infected cells and virus pro-
duction in lymphatic organs, the major site of HIV-1 and SIV
replication. Nonetheless, our data show that efficient class I MHC
downregulation is not sufficient to maintain high viral loads after
the onset of the antiviral CTL response. However, the observa-
tions that the viral RNA load was intermediate and that the
cell-associated viral load increased faster than in NU infection
provides some evidence that class I MHC downmodulation con-
tributes to the development of high viral loads in vivo in infected
rhesus macaques. Apparently a variety of complementary Nef
activities allows the virus to replicate at high levels in the great
majority of infected hosts.
Both the 64-67Nef and the previously analyzed 239(EDR)
Nef (34) are defective in at least four activities: downmodula-
tion of CD4, CD28, and CXCR4 and stimulation of viral rep-
lication. Thus, it is not possible to discern the relative contri-
butions of these functions to the attenuating effect of these
mutations. Ideally, mutations that are both selective for one
specific in vitro Nef function and difficult to revert should be
analyzed. However, although SIV Nef mutants that are appar-
ently exclusively impaired in class I MHC downregulation have
been described and analyzed in the SIV/macaque model (47,
60, 61), it is a difficult task to selectively disrupt other Nef
functions. In each case, the analysis of Nef mutants that are
impaired in multiple related functions also provides related
information on viral pathogenicity. Since these functions are
mediated by similar Nef surfaces, they will usually be se-
lected for in a linked manner in the infected host. Further-
more, therapeutic agents that disrupt one of these activities
will most likely also affect the others. However, it seems that
only agents that disrupt molecular interactions of Nef that
are critical for all of these in vitro functions will effectively
attenuate viral replication.
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